📰 Akumin News
Page 3 - Akumin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Akumin. Real-time updates on events, politics, business and more.
May 25, 2023
The law firm of Kirby McInerney LLP is investigating potential claims against Akumin Inc. . The investigation concerns whether Akumin and/or certain of its officers have violated the federal... | May 25, 2023
May 23, 2023
Akumin (NASDAQ:AKU – Get Rating) and Fresh2 Group (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership. Analyst Recommendations This is a summary of recent recommendations and […]
May 20, 2023
Akumin (NASDAQ:AKU – Get Rating) had its price objective reduced by National Bankshares from $0.50 to $0.25 in a report issued on Tuesday morning, BayStreet.CA reports. They currently have an underperform rating on the stock. Akumin Stock Performance NASDAQ:AKU opened at $0.39 on Tuesday. The company has a market capitalization of $35.30 million, a PE […]
May 18, 2023
Akumin (NASDAQ:AKU – Get Rating) had its price target lowered by equities research analysts at National Bankshares from $0.50 to $0.25 in a research note issued to investors on Tuesday, BayStreet.CA reports. The brokerage currently has an “underperform” rating on the stock. National Bankshares’ target price indicates a potential downside of 33.72% from the company’s […]
May 18, 2023
Akumin (NASDAQ:AKU – Get Rating) and Zicix (OTCMKTS:ZICX – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Institutional and Insider Ownership 25.8% of Akumin shares are owned by […]
May 16, 2023
Akumin (NASDAQ:AKU – Get Rating) had its price target dropped by National Bankshares from $0.50 to $0.25 in a report issued on Tuesday, BayStreet.CA reports. The brokerage currently has an “underperform” rating on the stock. National Bankshares’ target price points to a potential downside of 39.02% from the company’s previous close. Akumin Price Performance Shares […]
May 8, 2023
Akumin (NASDAQ:AKU – Get Rating) and OpGen (NASDAQ:OPGN – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership. Volatility and Risk Akumin has a beta of -0.49, suggesting that […]
May 4, 2023
Akumin (NASDAQ:AKU – Get Rating) and AnPac Bio-Medical Science (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk. Analyst Ratings This is a summary of recent recommendations […]
April 8, 2023
Akumin (NASDAQ:AKU – Get Rating) and Enzo Biochem (NYSE:ENZ – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, institutional ownership and valuation. Valuation & Earnings This table compares Akumin and Enzo Biochem’s […]
October 23, 2022
Akumin (NASDAQ:AKU – Get Rating) is one of 44 publicly-traded companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare Akumin to related businesses based on the strength of its dividends, analyst recommendations, institutional ownership, earnings, profitability, valuation and risk. Institutional and Insider Ownership 25.1% of Akumin shares […]